NASDAQ:PLRX

Pliant Therapeutics Stock Forecast

etoro logo Buy PLRX
*Your capital is at risk
$1.17
+0.0600 (+5.41%)
At Close: Jul 02, 2026
AI Analysis AI Analysis of PLRX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add PLRX to Watchlist?
  • Easy Tracking In The Watchlist
PDF

A very strong day for Pliant Therapeutics Inc. stock price on Thursday
(Updated on Jul 02, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Hold candidate since Jul 02, 2026

The Pliant Therapeutics Inc. stock price gained 5.41% on the last trading day (Thursday, 2nd Jul 2026), rising from $1.11 to $1.17. During the last trading day the stock fluctuated 5.86% from a day low at $1.11 to a day high of $1.18. The price has fallen in 4 of the last 10 days and is down by -0.85% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 394 thousand more shares were traded than the day before. In total, 702 thousand shares were bought and sold for approximately $821.46 thousand.

The stock lies in the middle of a falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -13.02% during the next 3 months and, with a 90% probability hold a price between $0.96 and $1.04 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

PLRX Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, July 01, 2026, and so far it has risen 5.41%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Pliant Therapeutics Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Pliant Therapeutics Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $1.17. On a fall, the stock will find some support from the short-term average at $1.14. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal.

Support, Risk & Stop-loss for Pliant Therapeutics Inc. stock

Pliant Therapeutics Inc. finds support from accumulated volume at $1.16 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $0.0650 between high and low, or 5.86%. For the last week the stock has had daily average volatility of 3.68%.

Our recommended stop-loss: $1.12 (-3.88%) (This stock has very low daily movements and this gives very low risk. There is a buy signal from a pivot bottom found 1 day ago.)

Trading Expectations (PLRX) For The Upcoming Trading Day Of Monday 6th

For the upcoming trading day on Monday, 6th we expect Pliant Therapeutics Inc. to open at $1.15, and during the day (based on 14 day Average True Range), to move between $1.15 and $1.19, which gives a possible trading interval of +/-$0.0463 (+/-4.04%) up or down from last closing price. If Pliant Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 4.04% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $1.18 (0.85%) than the support at $1.16 (0.85%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Pliant Therapeutics Inc. stock A Buy?

Pliant Therapeutics Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

Current score: -0.213 Hold/Accumulate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 6, 2026 - $1.15 ( 1.57%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

PLRX Performance

Trading levels for PLRX

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 1.22 3.99%
R2 1.19 1.87%
R1 1.18 0.555%
Price 1.17
S1 1.13 -3.69%
S2 1.11 -5.00%
S3 1.09 -7.12%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1.29 10.26%
R2 1.20 2.56%
R1 1.18 0.85%
Price 1.17
S1 1.16 -0.85%
S2 1.15 -1.71%
S3 1.14 -2.56%

FAQ

What is the symbol for Pliant Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Pliant Therapeutics Inc. is PLRX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Pliant Therapeutics Inc. Stock?
Pliant Therapeutics Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

How to buy Pliant Therapeutics Inc. Stock?
Pliant Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Pliant Therapeutics Inc. Stock.

What's the current price of Pliant Therapeutics Inc. Stock?
As of the end of day on the Jul 02, 2026, the price of an Pliant Therapeutics Inc. (PLRX) share was $1.17.

What is the 52-week high and low for Pliant Therapeutics Inc. Stock?
The 52-week high for Pliant Therapeutics Inc. Stock is $1.95 and the 52-week low is $1.09.

What is the market capitalization of Pliant Therapeutics Inc. Stock?
As of the Jul 02, 2026, the market capitalization of Pliant Therapeutics Inc. is 72.447M.

When is the next earnings date for Pliant Therapeutics Inc.?
The upcoming earnings date for Pliant Therapeutics Inc. is Aug 06, 2026.
Click to get the best stock tips daily for free!
ABOUT PLIANT THERAPEUTICS INC.
Pliant Therapeutics
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a trials. The company also develops PLN-1474, a small-molecule selective inhibitor of avß1, which complet...
GOLDEN STAR
Ticker Change Signal Date
B
BXDC
$21.71
1.11% Jun 29
SRPT
$17.02
13.28% Jun 29
OSIS
$218.29
1.59% Jun 26
NMRK
$15.02
4.66% Jun 24
JLL
$299.78
9.23% Jun 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE